$IQST
iQSTEL Inc Stock $iqst

$iqst Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000166357723000196 Filed on April 14, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$32.82M	$28.15M	$93.20M
YoY Change	38.5%	57.61%	44.05%
Cost Of Revenue	$32.04M	$29.00M	$91.41M
YoY Change	40.2%	63.86%	44.71%
Gross Profit	$784.5K	-$853.8K	$1.792M
YoY Change	-7.3%	-631.19%	16.81%
Gross Profit Margin	2.39%	-3.03%	1.92%
Selling, General & Admin	$953.1K	$1.252M	$4.351M
YoY Change	-12.01%	46.79%	0.72%
% of Gross Profit	121.49%		242.89%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$34.43K	$28.90K	$120.1K
YoY Change	19.47%	17.72%	31.32%
% of Gross Profit	4.39%		6.7%
Operating Expenses	$1.037M	$1.281M	$4.983M
YoY Change	-9.37%	50.18%	12.96%
Operating Profit	-$252.7K	-$2.135M	-$3.192M
YoY Change	-15.25%	208.34%	10.9%
Interest Expense	$126.2K	-$2.658M	-$2.680M
YoY Change	-3385.68%	9894.7%	647.77%
% of Operating Profit
Other Income/Expense, Net	$91.07K	$21.57K	-$2.674M
YoY Change	615.93%	-165.56%	-37710.42%
Pretax Income	-$161.6K	-$5.083M	-$5.866M
YoY Change	-43.37%	575.99%	51.81%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$213.9K	-$4.992M	-$5.967M
YoY Change	-39.08%	604.11%	55.49%
Net Earnings / Revenue	-0.65%	-17.74%	-6.4%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	-$0.03	-$0.04
COMMON SHARES
Basic Shares Outstanding	164.2M shares	155.3M shares
Diluted Shares Outstanding			151.9M shares

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.127M	$1.329M	$1.329M
YoY Change	-31.54%	-60.14%	-60.14%
Cash & Equivalents	$1.127M	$1.329M	$1.329M
Short-Term Investments
Other Short-Term Assets	$35.04K	$47.60K	$47.60K
YoY Change	-92.9%	104.12%	104.12%
Inventory	$28.12K	$26.12K	$26.12K
Prepaid Expenses	$571.4K	$545.6K
Receivables	$4.945M	$4.209M	$4.209M
Other Receivables	$962.9K	$824.3K	$824.3K
Total Short-Term Assets	$7.098M	$6.437M	$6.437M
YoY Change	4.1%	-1.98%	-1.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$473.5K	$401.0K	$401.0K
YoY Change	22.45%	-2.04%	-2.04%
Goodwill	$5.172M	$5.172M
YoY Change	0.0%	236.35%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$54.47K	$440.1K	$440.1K
YoY Change	-87.23%	-1.4%	-1.4%
Total Long-Term Assets	$6.254M	$6.113M	$6.113M
YoY Change	2.78%	145.19%	145.19%
TOTAL ASSETS
Total Short-Term Assets	$7.098M	$6.437M	$6.437M
Total Long-Term Assets	$6.254M	$6.113M	$6.113M
Total Assets	$13.35M	$12.55M	$12.55M
YoY Change	3.48%	38.52%	38.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.702M	$2.255M	$2.255M
YoY Change	7.35%	52.9%	52.9%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$253.5K	$94.34K	$0.00
YoY Change
Long-Term Debt Due	$251.2K	$94.34K	$330.3K
YoY Change	161.18%	-70.09%	-40.46%
Total Short-Term Liabilities	$6.912M	$6.452M	$6.452M
YoY Change	91.62%	173.03%	173.03%
LONG-TERM LIABILITIES
Long-Term Debt	$102.4K	$108.2K	$108.2K
YoY Change	-2.31%	-9.34%	-9.35%
Other Long-Term Liabilities	$159.3K	$154.2K	$154.2K
YoY Change	6.57%	-1.4%	-1.4%
Total Long-Term Liabilities	$261.8K	$262.4K	$262.4K
YoY Change	2.91%	-4.84%	-4.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.912M	$6.452M	$6.452M
Total Long-Term Liabilities	$261.8K	$262.4K	$262.4K
Total Liabilities	$7.174M	$6.714M	$5.790M
YoY Change	85.78%	154.44%	252.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.08M	-$24.50M
YoY Change	29.0%	32.19%
Common Stock	$164.7K	$161.6K
YoY Change	8.64%	9.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.843M	$6.760M	$6.760M
YoY Change
Total Liabilities & Shareholders Equity	$13.35M	$12.55M	$12.55M
YoY Change	3.48%	38.52%	38.52%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$213.9K	-$4.992M	-$5.967M
YoY Change	-39.08%	604.11%	55.49%
Depreciation, Depletion And Amortization	$34.43K	$28.90K	$120.1K
YoY Change	19.47%	17.72%	31.32%
Cash From Operating Activities	-$918.6K	-$276.2K	-$1.765M
YoY Change	-6.99%	-58.54%	-44.01%
INVESTING ACTIVITIES
Capital Expenditures	$69.00K	$25.58K	$112.1K
YoY Change	-409.42%	-119.94%	-148.54%
Acquisitions			$1.889M
YoY Change
Other Investing Activities	-$67.14K	-$74.70K	-$1.889M
YoY Change	-95.71%	1394.0%	573.71%
Cash From Investing Activities	-$136.1K	-$100.3K	-$2.002M
YoY Change	-91.42%	-24.75%	291.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.100M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	400.0K	400.0K	$1.768M
YoY Change		-86.38%	-71.72%
NET CHANGE
Cash From Operating Activities	-918.6K	-276.2K	-$1.765M
Cash From Investing Activities	-136.1K	-100.3K	-$2.002M
Cash From Financing Activities	400.0K	400.0K	$1.768M
Net Change In Cash	-654.7K	23.55K	-$2.005M
YoY Change	-74.57%	-98.9%	-177.51%
FREE CASH FLOW
Cash From Operating Activities	-$918.6K	-$276.2K	-$1.765M
Capital Expenditures	$69.00K	$25.58K	$112.1K
Free Cash Flow	-$987.6K	-$301.7K	-$1.877M
YoY Change	2.3%	-43.9%	-35.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001527702
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Inventory Net InventoryNet		usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	IQST	Preferred Stock Issued For Conversion Of Common Stock Value PreferredStockIssuedForConversionOfCommonStockValue		usd
CY2022	IQST	Write Off Of Due From Related Party WriteOffOfDueFromRelatedParty		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	IQST	Prepayment And Default Penalty PrepaymentAndDefaultPenalty		usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2020	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2020	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2020	IQST	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition		usd
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions		usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2020	IQST	Common Stock Issued For Exercise Of Cashless Warrants CommonStockIssuedForExerciseOfCashlessWarrants		usd
CY2022	IQST	Related Party Debt To Equity Swap Value RelatedPartyDebtToEquitySwapValue		usd
CY2022	IQST	Common Stock Issued For Forbearance Of Debt Value CommonStockIssuedForForbearanceOfDebtValue		usd
CY2022	IQST	Preferred Stock Issued For Conversion Of Common Stock PreferredStockIssuedForConversionOfCommonStock		usd
CY2022	IQST	Subscription Receivable SubscriptionReceivable		usd
CY2022Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable		usd
CY2021Q4	us-gaap	Advance Payments Netted Against Claim Receivable AdvancePaymentsNettedAgainstClaimReceivable		usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents		usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit		usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber		shares
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm
CY2022	IQST	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Increased By Vwap Outstanding Weighted Average Remaining Life ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncreasedByVWAPOutstandingWeightedAverageRemainingLife
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2022	IQST	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms Of Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOfForfeited
CY2021	us-gaap	Dividends Dividends		usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet		usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-55984
CY2022	dei	Entity Registrant Name EntityRegistrantName	IQSTEL Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-2808620
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	300 Aragon Avenue
CY2022	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 375
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Coral Gables
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33134
CY2022	dei	City Area Code CityAreaCode	954
CY2022	dei	Local Phone Number LocalPhoneNumber	951-8191
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	164176688	shares
CY2022	dei	Auditor Firm AuditorFirmId	1013
CY2022	dei	Auditor Name AuditorName	Urish Popeck & Co., LLC
CY2022	dei	Auditor Location AuditorLocation	Pittsburgh, PA
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1329389	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3334813	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4209125	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2540515	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	26124	usd
CY2022Q4	us-gaap	Due From Related Parties DueFromRelatedParties	326324	usd
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	424086	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	545628	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	267110	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6436590	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	6566524	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	401021	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	409382	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	99592	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	99592	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5172146	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1537742	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	440135	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	446402	usd
CY2022Q4	us-gaap	Assets Assets	12549484	usd
CY2021Q4	us-gaap	Assets Assets	9059642	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2254636	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1474595	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2482352	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	307049	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	26613	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	26613	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7406	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	94342	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	315450	usd
CY2022Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	235949	usd
CY2021Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	239308	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1357787	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6451679	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2363015	usd
CY2022Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	108150	usd
CY2021Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	119295	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	154238	usd
CY2021Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	156434	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6714067	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2638744	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1200000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1200000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	161595511	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	161595511	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	147477358	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	147477358	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	161595	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	147477	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	31136120	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25842982	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24504395	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18536921	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-33557	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-36658	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6759794	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	7416911	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-924377	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	-996013	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5835417	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6420898	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12549484	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9059642	usd
CY2022	us-gaap	Revenues Revenues	93203532	usd
CY2020	us-gaap	Revenues Revenues	64702018	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	91412016	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	63168303	usd
CY2022	us-gaap	Gross Profit GrossProfit	1791516	usd
CY2020	us-gaap	Gross Profit GrossProfit	1533715	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4983176	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4517631	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4983176	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	4517631	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3191660	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-2983916	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	118871	usd
CY2020	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4426	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-112962	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2684	usd
CY2022	IQST	Interest Expense2 InterestExpense2	29641	usd
CY2020	IQST	Interest Expense2 InterestExpense2	675481	usd
CY2022	IQST	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss1 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss1	-2650369	usd
CY2020	IQST	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss1 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss1	317080	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	528794	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2674101	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-880085	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5865761	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3864001	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5865761	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-3864001	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	101713	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-26228	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5967474	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-3837773	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5865761	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-3864001	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest	-6080	usd
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest	-74849	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-5859681	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3789152	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	104692	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	10448	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5964373	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3799600	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151850443	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	135383893	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1388575	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6436250	usd
CY2021	IQST	Common Stock Issued For Settlement Of Debt Value1 CommonStockIssuedForSettlementOfDebtValue1	2056530	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	284700	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1037568	usd
CY2021	IQST	Common Stock Issued For Forbearance Of Debt Value CommonStockIssuedForForbearanceOfDebtValue	49925	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	422295	usd
CY2021	IQST	Common Stock Payable Value CommonStockPayableValue	52161	usd
CY2021	IQST	Related Party Debt To Equity Swap Value RelatedPartyDebtToEquitySwapValue	1647150	usd
CY2021	IQST	Cancellation Of Common Stock Value CancellationOfCommonStockValue	-90104	usd
CY2021	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	708611	usd
CY2021	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	38173	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3837773	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	7416911	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1550000	usd
CY2022	IQST	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition	357500	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	107600	usd
CY2022	IQST	Common Stock Issued For Settlement Of Debt Value1 CommonStockIssuedForSettlementOfDebtValue1	80674	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	400000	usd
CY2022	IQST	Common Stock Payable Value CommonStockPayableValue	18900	usd
CY2022	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	1792582	usd
CY2022	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	3101	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5967474	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	6759794	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5865761	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-3864001	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	126500	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1284325	usd
CY2022	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	34376	usd
CY2020	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	0	usd
CY2020	IQST	Write Off Of Due From Related Party WriteOffOfDueFromRelatedParty	10148	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	120117	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	91474	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7407	usd
CY2020	us-gaap	Adjustment For Amortization AdjustmentForAmortization	450771	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	2650369	usd
CY2020	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-317080	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	528794	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	126818	usd
CY2022	IQST	Common Stock Payable Value CommonStockPayableValue	18900	usd
CY2020	IQST	Prepayment And Default Penalty PrepaymentAndDefaultPenalty	122020	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	799533	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	39862	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-26124	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	23728	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	91066	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	96863	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-265511	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1231946	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	2179965	usd
CY2020	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-95758	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1765060	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3152181	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1889132	usd
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	60000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	112074	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	153183	usd
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	77717	usd
CY2022	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	1000	usd
CY2020	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	220674	usd
CY2022	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	700	usd
CY2020	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	226	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2001506	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-511348	usd
CY2020	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	600000	usd
CY2022	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	232018	usd
CY2020	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	344483	usd
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	90787	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1100000	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6336250	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	400000	usd
CY2022	us-gaap	Proceeds From Derivative Instrument Financing Activities ProceedsFromDerivativeInstrumentFinancingActivities	500000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-250000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1767982	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6250980	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6840	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5954	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2005424	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2581497	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3334813	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	753316	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1329389	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3334813	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	3333	usd
CY2020	IQST	Common Stock Payable Value CommonStockPayableValue	52161	usd
CY2022	IQST	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition	357500	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1550000	usd
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	422295	usd
CY2022	IQST	Common Stock Issued For Exercise Of Cashless Warrants CommonStockIssuedForExerciseOfCashlessWarrants	3790	usd
CY2022	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	1792582	usd
CY2020	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	708611	usd
CY2020	IQST	Related Party Debt To Equity Swap Value RelatedPartyDebtToEquitySwapValue	1647150	usd
CY2022	IQST	Common Stock Issued For Settlement Of Debt Value2 CommonStockIssuedForSettlementOfDebtValue2	80674	usd
CY2020	IQST	Common Stock Issued For Settlement Of Debt Value2 CommonStockIssuedForSettlementOfDebtValue2	2056530	usd
CY2020	IQST	Common Stock Issued For Forbearance Of Debt Value CommonStockIssuedForForbearanceOfDebtValue	49925	usd
CY2020	IQST	Preferred Stock Issued For Conversion Of Common Stock PreferredStockIssuedForConversionOfCommonStock	21	usd
CY2020	IQST	Subscription Receivable SubscriptionReceivable	100000	usd
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2011-06-24
CY2022	IQST	Covid19 Covid19	<p id="xdx_846_ecustom--Covid19_zWmd4a9pwVGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><i>COVID-19</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">A novel strain of coronavirus (COVID-19) was first identified in December 2019, and subsequently declared a global pandemic by the World Health Organization on March 11, 2020. As a result of the outbreak, many companies experienced disruptions in their operations and in markets served. The Company has instituted some and may take additional temporary precautionary measures intended to help ensure the well-being of its employees and minimize business disruption. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at December 31, 2022. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A new prolonged outbreak could have a material adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to collect accounts receivable and the ability of the Company to continue to provide high quality services to its clients. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or lia</span>bilities as of April 14, 2023, the d<span style="background-color: white">ate of issuance of this Annual Report on Form 10-K. These estimates may change, as new events occur, and additional information is obtained.</span></p>
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	23320	usd
CY2022Q4	us-gaap	Advance Payments Netted Against Claim Receivable AdvancePaymentsNettedAgainstClaimReceivable	21000	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	389	usd
CY2021Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	603	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	357500	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	20000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	545628	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	267110	usd
CY2022	us-gaap	Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable	2022-09-30
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	500000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_z7crgZqMneSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">The preparation of the consolidated financial statements in conformity with GAAP in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	235949	usd
CY2021Q4	us-gaap	Loans Payable LoansPayable	239308	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	235949	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	239308	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	1647150	usd
CY2022	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	34376	usd
CY2021	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	0	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	372290	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	250000	usd
CY2021	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	708611	usd
CY2022	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_80B_eus-gaap--DerivativesReportingOfDerivativeActivity_zpvcFgboAdv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 9 – WARRANTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On April 5, 2022, we entered into a Common Stock Purchase Option Agreement with Apollo Management Group, Inc (Holder) to subscribe for and purchase from the Company, <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20221231_zzkVkPpzIkaa">4,800,000</span> shares of Common Stock with an exercise price per share of <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20211231__20211231_zpnbFItXeiW6">$2.00</span>; and an initial exercisable date on <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_c20220101__20221231_zrrGigxSAHla">September 30, 2022</span>. The purchase price of this option was <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20220405_ziAIiZcopDv8">$500,000</span>. The Company determined that the warrants had a fixed monetary value with a variable number of shares at inception and categorized the warrants as a liability in the accompanying consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_90E_eus-gaap--OptionIndexedToIssuersEquitySettlementAlternatives_c20220101__20221231_ze7KsxrnOan6">The Holder and the Company agreed that the Holder had the right and the obligation to exercise, on a cashless basis, $1,000,000 of the Options not later than October 15, 2022. Thereafter, the Holder shall undertake to exercise not less than (i) <span id="xdx_90E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20221114_zRKzRvijty9">$400,000</span> of the Options on a “cash basis” not later than the later of (y) November 14, 2022 or (z) the date on which there is an effective registration statement permitting the issuance of the Option Shares to or resale of the Option Shares by the Holder and (ii) an additional <span id="xdx_90E_eus-gaap--WarrantsNotSettleableInCashFairValueDisclosure_iI_c20221214_zC0IP0QCh9L7">$400,000</span> of the Options on a “cash basis” not later than the latest of (x) thirty (30) days following the exercise of the Option under subsection (i), above, (y) December 14, 2022, or (z) the date on which there is an effective registration statement permitting the issuance of the Option Shares to or resale of the Option Shares by the Holder. From and after the occurrence of the three above-referenced exercises, each additional exercise of Options hereunder shall be in an amount not less than $200,000 and exercised only on a cash basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_90A_eus-gaap--DebtInstrumentCallFeature_c20220101__20221231__us-gaap--ClassOfWarrantOrRightAxis__custom--ApolloManagementGroupMember_zVvSFhe0XAF5">The Holder’s obligation to exercise each specified portion of this option on the specific dates above is subject to the volume-weighted average price (“VWAP”, market value), being not less than $0.20 per share on the relevant option exercise date. Adjusted option shares at VWAP of $0.20 shall be 48,000,000 shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">A summary of activity regarding warrants issued as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zoOz06Baen6f" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - NOTE 9 - WARRANTS - Schedule of Warrant Summary (Details)"> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Warrants Outstanding</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining</td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Warrants</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Contractual life (in years)</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt">Outstanding, December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20211231_z6e5aEkOgB67"><span style="-sec-ix-hidden: xdx2ixbrl1045">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20211231_z92SCDcEvyF7"><span style="-sec-ix-hidden: xdx2ixbrl1046">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_d0_c20211231_zR7N9tD7ML6d"><span style="-sec-ix-hidden: xdx2ixbrl1047">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 41%; padding-left: 5.4pt">Granted</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20220101__20221231_zg4MClAfSY72">4,800,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20211231__20211231_zAbQdMpkaJ35">2.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right"><span id="xdx_906_ecustom--WeightedAverageRemainingLifeOfWarrantsGrantedInPeriod_dtY_c20220101__20221231_zaM9J1Kj0Wtk">1.49</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">Increase in number of warrants by VWAP</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease_c20220101__20221231_zKr2XeDHfBY8">32,467,713</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--IncreaseInNumberOfWarrantsWeightedAverageExercisePrice_c20211231__20211231_zUVPdFd1q5ih">0.17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIncreasedByVWAPOutstandingWeightedAverageRemainingLife_d0_c20220101__20221231_zLGVa3kKX1Dl"><span style="-sec-ix-hidden: xdx2ixbrl1053">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 5.4pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20220101__20221231_zpe3PHdXoNK7">14,155,138</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20211231__20211231_zP5CmI7yIine">0.18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231_zWkEUZFU78Qi">0.97</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 5.4pt">Forfeited/canceled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20220101__20221231_zRYW6sQlSgff"><span style="-sec-ix-hidden: xdx2ixbrl1057">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20211231__20211231_zVWhdH52FYs5"><span style="-sec-ix-hidden: xdx2ixbrl1058">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOfForfeited_d0_c20220101__20221231_zWh0wEZFOtsb"><span style="-sec-ix-hidden: xdx2ixbrl1059">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 5.4pt">Outstanding, December 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20221231_zjXOArtCRqHl">23,112,575</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_iI_c20221231_z1DqbahF4FBg">0.17</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231_z5QPoonQ9QRe">0.75</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"/> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="margin-top: 0; margin-bottom: 0"/> <p style="margin-top: 0pt; margin-bottom: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/>
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	4800000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.00
CY2022	IQST	Conideration Of Whisl ConiderationOfWhisl	<table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ConiderationOfWhisl_zJAKw013qVoc" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - NOTE 4 - ACQUISITIONS - Whisl Consideration (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; font-size: 11pt"> </td><td style="font-weight: bold"> </td> <td colspan="3" style="font-weight: bold; text-align: center">May 13,</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair Value of Consideration:</b></span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 31%; text-align: right"><span id="xdx_902_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20220513__us-gaap--BusinessAcquisitionAxis__custom--WhislTelecomLLCMember_zA5cdtUtV8zh">1,250,000</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220513__20220513__us-gaap--BusinessAcquisitionAxis__custom--WhislTelecomLLCMember_zIjRHPEbdN82">1,461,653</span> shares of common stock</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20220513__20220513__us-gaap--BusinessAcquisitionAxis__custom--WhislTelecomLLCMember__us-gaap--StatementClassOfStockAxis__us-gaap--RestrictedStockMember_z6G8MKTntXWa">550,000</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; font-size: 11pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Purchase Price</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--AcquisitionCostsCumulative_iI_c20220601__us-gaap--BusinessAcquisitionAxis__custom--SmartbizTelecomLLCMember_zJ6tx6lX24R1">1,800,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022	IQST	Conideration Of Smartbiz ConiderationOfSmartbiz	<table cellpadding="0" cellspacing="0" id="xdx_88E_ecustom--ConiderationOfSmartbiz_zY6nQwiaFWk8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - NOTE 4 - ACQUISITIONS - Smartbiz Consideration (Details)"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="3" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 1,</td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><b>Fair Value of Consideration:</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 31%; text-align: right"><span id="xdx_906_eus-gaap--BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_iI_c20220601__us-gaap--BusinessAcquisitionAxis__custom--SmartbizTelecomLLCMember_zpXbHPSRKRq9">800,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220501__20220601__us-gaap--BusinessAcquisitionAxis__custom--SmartbizTelecomLLCMember_zEDnF268Wrrj">2,850,330</span> shares of common stock</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20220501__20220601__us-gaap--BusinessAcquisitionAxis__custom--SmartbizTelecomLLCMember_zIqQ8rD8TMqa">1,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Purchase Price</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--AcquisitionCostsCumulative_iI_c20220601__us-gaap--BusinessAcquisitionAxis__custom--SmartbizTelecomLLCMember_z4vVlNOf6mrj">1,800,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2021Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	100000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	120139	usd
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	143187	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	26600	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	656629	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	576419	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	401021	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	409382	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	120117	usd
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	91474	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	202492	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	442151	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	202492	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	434745	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	94342	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	315450	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	108150	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	119295	usd
CY2022	us-gaap	Option Indexed To Issuers Equity Settlement Alternatives OptionIndexedToIssuersEquitySettlementAlternatives	The Holder and the Company agreed that the Holder had the right and the obligation to exercise, on a cashless basis, $1,000,000 of the Options not later than October 15, 2022. Thereafter, the Holder shall undertake to exercise not less than (i) $400,000 of the Options on a “cash basis” not later than the later of (y) November 14, 2022 or (z) the date on which there is an effective registration statement permitting the issuance of the Option Shares to or resale of the Option Shares by the Holder and (ii) an additional $400,000 of the Options on a “cash basis” not later than the latest of (x) thirty (30) days following the exercise of the Option under subsection (i), above, (y) December 14, 2022, or (z) the date on which there is an effective registration statement permitting the issuance of the Option Shares to or resale of the Option Shares by the Holder. From and after the occurrence of the three above-referenced exercises, each additional exercise of Options hereunder shall be in an amount not less than $200,000 and exercised only on a cash basis.
CY2022Q4	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	400000	usd
CY2022Q4	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	400000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	4800000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.00
CY2022	IQST	Weighted Average Remaining Life Of Warrants Granted In Period WeightedAverageRemainingLifeOfWarrantsGrantedInPeriod	P1Y5M26D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease	32467713	shares
CY2021Q4	IQST	Increase In Number Of Warrants Weighted Average Exercise Price IncreaseInNumberOfWarrantsWeightedAverageExercisePrice	0.17
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	14155138	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0.18
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P0Y11M19D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	23112575	shares
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.17
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P0Y9M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0006	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0473	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0007	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0009	pure
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	1025691	usd
CY2021	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	708611	usd
CY2021	us-gaap	Debt Securities Held To Maturity Transfer Derivative Hedge Gain Loss DebtSecuritiesHeldToMaturityTransferDerivativeHedgeGainLoss	317080	usd
CY2022	us-gaap	Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts	500000	usd
CY2022	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	943833	usd
CY2022	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	1792582	usd
CY2022	us-gaap	Debt Securities Held To Maturity Transfer Derivative Hedge Gain Loss DebtSecuritiesHeldToMaturityTransferDerivativeHedgeGainLoss	1706536	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	1357787	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	943833	usd
CY2022	IQST	Revaluation Of Derivative Liabilities RevaluationOfDerivativeLiabilities	1706536	usd
CY2021	IQST	Revaluation Of Derivative Liabilities RevaluationOfDerivativeLiabilities	317080	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	2650369	usd
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	317080	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	21000000	shares
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	14118153	shares
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1550000	usd
CY2022	IQST	Stock Issued During Period Value Asset Acquisition StockIssuedDuringPeriodValueAssetAcquisition	357500	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	107600	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	400000	usd
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	51638526	shares
CY2021	IQST	Subscription Receivable SubscriptionReceivable	100000	usd
CY2022Q1	us-gaap	Common Stock Shares Subscriptions CommonStockSharesSubscriptions	100000	usd
CY2021	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	1516667	usd
CY2021	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	195000	shares
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	284700	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1037568	usd
CY2021	IQST	Common Stock Issued For Forbearance Of Debt Value CommonStockIssuedForForbearanceOfDebtValue	49925	usd
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	422295	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	161595511	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	161595511	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	147477358	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	147477358	shares
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	-15540294	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	-12332310	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	21	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	21	pure
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3263462	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2589785	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	-7118	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	-7242	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-2816209	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	-2136141	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	440135	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	446402	usd
CY2022Q4	IQST	Deferred Tax Assets Operating Loss Carryforwards Approximate DeferredTaxAssetsOperatingLossCarryforwardsApproximate	-15540000	usd
CY2022	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	10148	usd
CY2022Q4	us-gaap	Due From Related Parties DueFromRelatedParties	326324	usd
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	424086	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	26613	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	26613	usd
CY2021	IQST	Related Party Debt To Equity Swap Value RelatedPartyDebtToEquitySwapValue	1647150	usd
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense	576000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	558000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	107600	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1037568	usd
CY2022Q4	us-gaap	Financial Guarantee Insurance Contracts Risk Management Activities Mitigating Claim Liabilities Accrued Liabilities FinancialGuaranteeInsuranceContractsRiskManagementActivitiesMitigatingClaimLiabilitiesAccruedLiabilities	79628	usd
CY2021Q4	us-gaap	Financial Guarantee Insurance Contracts Risk Management Activities Mitigating Claim Liabilities Accrued Liabilities FinancialGuaranteeInsuranceContractsRiskManagementActivitiesMitigatingClaimLiabilitiesAccruedLiabilities	92229	usd
CY2022Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	73865	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	37823	usd
CY2022	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	5000	usd
CY2021Q1	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	12600	usd
CY2022	us-gaap	Revenues Revenues	93203532	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	91412016	usd
CY2022	us-gaap	Gross Profit GrossProfit	1791516	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4983176	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3191660	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2674101	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5865761	usd
CY2021	us-gaap	Revenues Revenues	64702018	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	63168303	usd
CY2021	us-gaap	Gross Profit GrossProfit	1533715	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4517631	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-2983916	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-880085	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-3864001	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	6436590	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6112894	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6451679	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	262388	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	6566524	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	2493118	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2363015	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	275729	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	2941177	usd
	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	400000	shares

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
iqst-20221231_def.xml	Edgar Link	unprocessable
iqst-20221231_lab.xml	Edgar Link	unprocessable
iqst-20221231_cal.xml	Edgar Link	unprocessable
iqst-20221231_pre.xml	Edgar Link	unprocessable
0001663577-23-000196-index-headers.html	Edgar Link	pending
0001663577-23-000196-index.html	Edgar Link	pending
0001663577-23-000196.txt	Edgar Link	pending
0001663577-23-000196-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
iqst-20221231.xsd	Edgar Link	pending
iqst10k123122.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
iqst10k123122_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IQST
iQSTEL Inc Stock $iqst

2023 Q2 Form 10-K Financial Statement

#000166357723000196 Filed on April 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IQST iQSTEL Inc Stock $iqst

2023 Q2 Form 10-K Financial Statement

#000166357723000196 Filed on April 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IQST
iQSTEL Inc Stock $iqst